In our opinion, Pharma has just started after 5 years of weakness and we have been super bullish on it for the last 4 months. Both in our #Bluechip#Investing strategy (Largecaps) and #growthinvesting strategy (Mid and smallcaps), #pharma sector allocation has been more than 25%, leading to super performance.